Federal University of Sao Paulo
Brazil
Benedikt Fischer spends much of his time researching Psychiatry, Environmental health, Psychological intervention, Public health and Medical prescription. His study on Methadone maintenance, Heroin, Use Heroin and Substance abuse is often connected to Opioid use as part of broader study in Psychiatry. His work deals with themes such as Law enforcement, Health care and Cannabis, which intersect with Environmental health.
Benedikt Fischer interconnects Pharmacy, Modalities and PsycINFO in the investigation of issues within Psychological intervention. The study incorporates disciplines such as Mental health and Evidence-based medicine, MEDLINE in addition to Public health. His study explores the link between Harm reduction and topics such as Politics that cross with problems in Public relations.
His main research concerns Psychiatry, Public health, Environmental health, Psychological intervention and Cannabis. His Public health research is multidisciplinary, incorporating perspectives in Medical prescription, Demography, Epidemiology and Substance abuse. His Epidemiology study combines topics in areas such as Genotype and Hepatitis C virus.
His Environmental health research includes themes of Occupational safety and health and Harm. Benedikt Fischer has researched Psychological intervention in several fields, including Family medicine, Mental health and Clinical psychology. His Cannabis study incorporates themes from Legalization, Public opinion and MEDLINE.
His primary areas of investigation include Public health, Environmental health, Cannabis, Epidemiology and Psychiatry. He has included themes like Psychological intervention, Medical prescription, Demography and Intervention in his Public health study. He works mostly in the field of Medical prescription, limiting it down to topics relating to Methadone and, in certain cases, Fentanyl.
His work carried out in the field of Environmental health brings together such families of science as Logistic regression, Hepatitis C virus, Substance abuse, Occupational safety and health and Hepatitis B virus. His work on Cannabis use as part of general Cannabis research is frequently linked to Human factors and ergonomics, thereby connecting diverse disciplines of science. His work in the fields of Psychiatry, such as Heroin and Psychosocial, overlaps with other areas such as Naloxone and Paradigm shift.
The scientist’s investigation covers issues in Public health, Psychiatry, Epidemiology, Cannabis and Psychological intervention. In the subject of general Public health, his work in Health psychology is often linked to Opioid overdose, thereby combining diverse domains of study. His research on Psychiatry frequently connects to adjacent areas such as Hepatic disorders.
The concepts of his Epidemiology study are interwoven with issues in Medical microbiology, Virology, High prevalence and Environmental health. His Cannabis research is multidisciplinary, relying on both Legalization, Demography, MEDLINE and Confidence interval. His Suicide prevention research is multidisciplinary, incorporating elements of Injury prevention and Human factors and ergonomics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Drug Policy and the Public Good
Thomas F. Babor;Jonathan P. Caulkins;Griffith Edwards;Benedikt Fischer.
(2010)
Cannabis Policy: Moving Beyond Stalemate
Robin Room;Benedikt Fischer;Wayne Hall;Simon Lenton.
(2010)
The Costs of Substance Abuse in Canada 2002
Jürgen Rehm;D Baliunas;S Brochu;B Fischer.
Rehm, Jürgen; Baliunas, D; Brochu, S; Fischer, B; Gnam, W; Patra, J; Popova, S; Sarnocinska-Hart, A; Taylor, B (2006). The costs of substance abuse in Canada 2002. Ottawa and Canada: Canadian Centre on Substance Abuse. (2006)
Drug policy and the public good: evidence for effective interventions
John Strang;Thomas Babor;Jonathan Caulkins;Jonathan Caulkins;Benedikt Fischer;Benedikt Fischer.
(2012)
Management of opioid use disorders: a national clinical practice guideline
Julie Bruneau;Keith Ahamad;Marie-Ève Goyer;Ginette Poulin.
Canadian Medical Association Journal (2018)
Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
Jason Grebely;Jason Grebely;Krista A. Genoway;Krista A. Genoway;Jesse D. Raffa;Gurbir Dhadwal.
Drug and Alcohol Dependence (2008)
Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.
J. Grebely;J. D. Raffa;C. Lai;M. Krajden.
Journal of Viral Hepatitis (2009)
Illicit opioid use in Canada: Comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study)
Benedikt Fischer;Jürgen Rehm;Suzanne Brissette;Serge Brochu.
Journal of Urban Health-bulletin of The New York Academy of Medicine (2005)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Benedikt Fischer;Cayley Russell;Pamela Sabioni;Wim van den Brink.
American Journal of Public Health (2017)
The costs of alcohol, illegal drugs, and tobacco in Canada, 2002
Jürgen Rehm;William Gnam;Svetlana Popova;Dolly Baliunas.
Journal of Studies on Alcohol and Drugs (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Toronto
La Trobe University
King's College London
University of British Columbia
Oxford Brookes University
Stanford University
University of Maryland, College Park
Carnegie Mellon University
University of Connecticut
University of Queensland
University of Edinburgh
University of South Australia
City University of Hong Kong
Virginia Tech
Aviation Australia
Nanjing University
University of Pittsburgh
Polytechnique Montréal
University of Vermont
Kanazawa University
Kindai University
Cedars-Sinai Medical Center
Duke University
GNS Science
Osaka University
Rush University Medical Center